Cargando…

Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives

PURPOSE: Multiple sclerosis (MS) prognosis is often uncertain. This literature review considers patients’ understanding of, and perspectives on, MS progression to better comprehend the unmet needs of people with MS (PwMS), in order to improve treatment adherence and quality of life (QoL). METHODS: L...

Descripción completa

Detalles Bibliográficos
Autores principales: Celius, Elisabeth G, Thompson, Heidi, Pontaga, Maija, Langdon, Dawn, Laroni, Alice, Potra, Stanca, Bharadia, Trishna, Yeandle, David, Shanahan, Jane, van Galen, Pieter, Alexandri, Nektaria, Kesselring, Jürg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802794/
https://www.ncbi.nlm.nih.gov/pubmed/33447018
http://dx.doi.org/10.2147/PPA.S268829
_version_ 1783635816741863424
author Celius, Elisabeth G
Thompson, Heidi
Pontaga, Maija
Langdon, Dawn
Laroni, Alice
Potra, Stanca
Bharadia, Trishna
Yeandle, David
Shanahan, Jane
van Galen, Pieter
Alexandri, Nektaria
Kesselring, Jürg
author_facet Celius, Elisabeth G
Thompson, Heidi
Pontaga, Maija
Langdon, Dawn
Laroni, Alice
Potra, Stanca
Bharadia, Trishna
Yeandle, David
Shanahan, Jane
van Galen, Pieter
Alexandri, Nektaria
Kesselring, Jürg
author_sort Celius, Elisabeth G
collection PubMed
description PURPOSE: Multiple sclerosis (MS) prognosis is often uncertain. This literature review considers patients’ understanding of, and perspectives on, MS progression to better comprehend the unmet needs of people with MS (PwMS), in order to improve treatment adherence and quality of life (QoL). METHODS: Literature searches for peer-reviewed papers concerning patient perspectives on the progression of MS and comparable conditions, published between January 2000 and January 2020, were conducted. RESULTS: Little qualitative evidence exists that examines PwMS’ perspectives on MS progression. The understanding and meaning ascribed to terms such as “disease progression” vary. Some PwMS find disease labels stigmatizing, confusing, and disconnected from reality. The lack of a clear definition of progression and discrepancies between PwMS and healthcare professional (HCP) perspectives may contribute to misunderstanding and poor communication. Patient descriptions of progression and relapses include symptoms in addition to those evaluated by standard severity and disability measures. Compared with HCPs, PwMS are still focused on relapse prevention but place higher priority on QoL and ascribe different relative importance to the causes of poor adherence to treatment plans. PwMS want to discuss progression and likely prognosis. Such communication needs to be personalized and delivered with sensitivity, at an appropriate time. Poor treatment adherence may arise from a lack of understanding and poor communication, particularly around treatment goals. The few studies that directly considered patient perspectives on the progression of comparable conditions supported and extended the perspectives of PwMS. Lack of adequate communication by HCPs was the most common theme. CONCLUSION: Patient perspectives on disease progression in MS and other chronic progressive conditions are under-investigated and under-reported. The limited evidence available highlights the importance of providing adequate information and effective HCP communication. While further studies are needed, the current evidence base offers information and insights that may help HCPs to enhance patient care, well-being, and treatment adherence.
format Online
Article
Text
id pubmed-7802794
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-78027942021-01-13 Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives Celius, Elisabeth G Thompson, Heidi Pontaga, Maija Langdon, Dawn Laroni, Alice Potra, Stanca Bharadia, Trishna Yeandle, David Shanahan, Jane van Galen, Pieter Alexandri, Nektaria Kesselring, Jürg Patient Prefer Adherence Review PURPOSE: Multiple sclerosis (MS) prognosis is often uncertain. This literature review considers patients’ understanding of, and perspectives on, MS progression to better comprehend the unmet needs of people with MS (PwMS), in order to improve treatment adherence and quality of life (QoL). METHODS: Literature searches for peer-reviewed papers concerning patient perspectives on the progression of MS and comparable conditions, published between January 2000 and January 2020, were conducted. RESULTS: Little qualitative evidence exists that examines PwMS’ perspectives on MS progression. The understanding and meaning ascribed to terms such as “disease progression” vary. Some PwMS find disease labels stigmatizing, confusing, and disconnected from reality. The lack of a clear definition of progression and discrepancies between PwMS and healthcare professional (HCP) perspectives may contribute to misunderstanding and poor communication. Patient descriptions of progression and relapses include symptoms in addition to those evaluated by standard severity and disability measures. Compared with HCPs, PwMS are still focused on relapse prevention but place higher priority on QoL and ascribe different relative importance to the causes of poor adherence to treatment plans. PwMS want to discuss progression and likely prognosis. Such communication needs to be personalized and delivered with sensitivity, at an appropriate time. Poor treatment adherence may arise from a lack of understanding and poor communication, particularly around treatment goals. The few studies that directly considered patient perspectives on the progression of comparable conditions supported and extended the perspectives of PwMS. Lack of adequate communication by HCPs was the most common theme. CONCLUSION: Patient perspectives on disease progression in MS and other chronic progressive conditions are under-investigated and under-reported. The limited evidence available highlights the importance of providing adequate information and effective HCP communication. While further studies are needed, the current evidence base offers information and insights that may help HCPs to enhance patient care, well-being, and treatment adherence. Dove 2021-01-08 /pmc/articles/PMC7802794/ /pubmed/33447018 http://dx.doi.org/10.2147/PPA.S268829 Text en © 2021 Celius et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Celius, Elisabeth G
Thompson, Heidi
Pontaga, Maija
Langdon, Dawn
Laroni, Alice
Potra, Stanca
Bharadia, Trishna
Yeandle, David
Shanahan, Jane
van Galen, Pieter
Alexandri, Nektaria
Kesselring, Jürg
Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives
title Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives
title_full Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives
title_fullStr Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives
title_full_unstemmed Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives
title_short Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives
title_sort disease progression in multiple sclerosis: a literature review exploring patient perspectives
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802794/
https://www.ncbi.nlm.nih.gov/pubmed/33447018
http://dx.doi.org/10.2147/PPA.S268829
work_keys_str_mv AT celiuselisabethg diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives
AT thompsonheidi diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives
AT pontagamaija diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives
AT langdondawn diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives
AT laronialice diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives
AT potrastanca diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives
AT bharadiatrishna diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives
AT yeandledavid diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives
AT shanahanjane diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives
AT vangalenpieter diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives
AT alexandrinektaria diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives
AT kesselringjurg diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives